Based on these studies and our observations, one can propose that HDACi-related immunity is first mediated by the recognition of NKG2D ligands on the surface of treated tumor cells, and then followed by HSP70-mediated priming of T cells. The gene discussed is KLRK1; the disease is neoplasm.